Tonghe Pharmaceutical (300636.SZ) released its report for the first quarter of 2024, with revenue of 206 million yuan, and...
According to the Zhitong Finance App, Tonghe Pharmaceutical (300636.SZ) released its report for the first quarter of 2024, with revenue of 206 million yuan, a year-on-year decrease of 6.47%. Net profit attributable to shareholders of listed companies was 43.5628 million yuan, an increase of 31.62% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 404.8876 million yuan, an increase of 23.31% over the previous year. Basic earnings per share were $0.1037.